Broccoli Sprout Extract for Cognitive Function
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-85
SponsorPusan National University Yangsan Hospital
About this trial
This clinical trial aims to determine whether broccoli sprout extract improves cognitive function in adults with mild cognitive impairment and to assess its safety.
The main questions are:
* Does broccoli sprout extract improve cognitive function in participants? * What side effects occur when participants take broccoli sprout extract?
Eligibility criteria
Qualifiers
Age: Adults aged 55-85 years (inclusive), both male and female
Absence of dementia according to established diagnostic criteria
Ability to read Korean
Disqualifiers
Severe medical conditions within the past 6 months: History of severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage), cardiac disease (angina, myocardial infarction, heart failure, arrhythmia requiring treatment), or malignancy (Note: Participants with a history of cerebrovascular or cardiac disease who are clinically stable may be included at the investigator's discretion)
Cognitive impairment-associated diseases: Dementia, Parkinson's disease, cerebral infarction, or other conditions associated with cognitive decline Uncontrolled hypertension: Blood pressure ≥160/100 mmHg (measured after 10 minutes of rest)
Poor glycemic control: Fasting blood glucose ≥160 mg/dL in diabetic patients
Uncontrolled thyroid dysfunction: Currently receiving treatment for uncontrolled hypothyroidism or hyperthyroidism
Trial design
Treatments tested in this trial
- Broccoli sprout extract (BSE)
- Placebo Control
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov